Room temperature ionic liquids (ILs) have many applications including as matrices in MALDI. We wished to investigate the efficacy of ILs as matrices in time-of-flight secondary ion mass spectrometry and in mass spectrometric imaging (MS imaging). Two ILs derived from alpha-cyano-4-hydroxycinnamic acid (CHCA) were synthesized and tested using phospholipids, cholesterol, and peptides. The molecular ion intensities of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE), cholesterol, and bradykinin were greatly increased using IL matrices. Further, detection limits were also improved: for DPPC and DPPE detection, limits were at least 2 orders of magnitude better using IL matrices. However, these IL matrices were not effective for the enhancement of angiotensin I ions. The data also indicate that IL matrices are suitable for imaging MS. The IL matrices did not cause changes to the sample surface via matrix crystallization or other processes; no "hot spots" were observed in the mass spectra. As a demonstration, an onionskin membrane was imaged. In the matrix-enhanced MS images, ions characteristic of proteins and other biomolecules were observed which could not otherwise be observed. Clearly ionic liquids deserve further investigation in SIMS and MS imaging.

Background Unnecessary laboratory testing of hospitalized patients is prevalent. Objective We conducted a study focused on “mindful ordering” to decrease unnecessary laboratory ordering within an Internal Medicine residency program. Designs, Settings and Participants We collected survey data on resident/faculty perceptions of laboratory ordering as well as order information from the electronic medical record (EMR). Intervention Interventions focused on resident‐identified barriers such as knowledge, EMR, habit and faculty expectations. Interventions were cumulative and included resident/faculty education and EMR optimization. Main Outcomes and Measures We assessed basic and complete metabolic panels (BMP, CMP) and complete blood counts with and without differential (CBC w/diff, w/o diff). Primary outcomes included: total labs ordered per week, lab and frequency, and resident perception of ordering practices. Secondary outcomes included: length‐of stay (LOS) and venipuncture utilization. Results Survey data demonstrated increased resident perception of both mindful ordering and team discussion. Total labs ordered per week decreased 20% in the first year (1944 to 1500 labs/week). Residents' use of the “one‐time draw” option increased; use of “daily” frequency decreased. Trends showed an increase in BMP relative to CMP, and an increase in CBC w/o diff relative to CBC w/diff. These changes were sustained through 127 weeks. There was an approximately 10% decrease in monthly average of patients undergoing venipuncture each day (86.7% to 74.2%). The shifts in laboratory ordering in conjunction with increased discussion about labs suggest a sustained change in resident lab ordering behavior. This study shows the impact of focusing interventions on resident‐identified barriers to mindful ordering to create a sustained decrease laboratory orders.

Objective:Rare disease Background:During the COVID-19 pandemic, the incidence of opportunistic infections, including fungal infections, has increased. Blastomycosis is caused by inhalation of an environmental fungus, Blastomyces dermatides, which is endemic in parts of the USA and Canada. This case report is of a 44-year-old man from the American Midwest who presented with disseminated blastomycosis infection 3 months following a diagnosis of COVID-19. Case Report:Our patient initially presented to an outpatient clinic with mild upper-respiratory symptoms. He tested positive for SARS-CoV-2 via polymerase chain reaction (PCR). Three months later, he presented to our emergency department due to some unresolved COVID-19 symptoms and the development of a widely disseminated, painful rash of 1-week duration. A positive Blastomyces urine enzyme immunoassay was the first indication of his diagnosis, which was followed by the identification of the pathogen via fungal culture from bronchoscopy samples and pathology from lung and skin biopsies. Given the evidence of dissemination, the patient was treated with an intravenous and oral antifungal regimen. He recovered well after completing treatment. Conclusions:The immunocompetent status of patients should not exclude disseminated fungal infections as a differential diagnosis, despite the less frequent manifestations. This is especially important when there is a history of COVID-19, as this may predispose once-healthy individuals to more serious disease processes. This case supports the recent recommendations made by the U.S. Centers for Disease Control and Prevention (CDC) for increased vigilance regarding fungal infections in patients with a history of COVID-19.